Source: The Business Journals: Greensboro/Winston-Salem/High Point

Oncoceutics: Durham biotech makes $78M deal for Philly firm to boost platform for cancer treatment

The Durham-based biopharmaceutical firm is aiming to boost its pipeline of drugs designed to combat recurrent glioma - a form of brain cancer.

Read full article »
Oncoceutics's Competitors | Oncoceutics's News | Oncoceutics's Financials
Stay up-to-date with the latest news on Oncoceutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Lee Schalop's photo - Co-Founder & CEO of Oncoceutics

Co-Founder & CEO

Lee Schalop

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Oncoceutics